Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma ☆
Titel:
Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma ☆
Auteur:
Agarwal, N. Brugarolas, J. Ghatalia, P. George, S. Haanen, J.B. Gurney, H. Ravilla, R. Van der Veldt, A. Beuselinck, B. Pokataev, I. Suelmann, B.B.M. Tuthill, M.H. Vaena, D. Zagouri, F. Wu, J. Perini, R.F. Liu, Y. Merchan, J. Atkins, M.B.